Announcement Summary
- Company: Veerhealth Care Ltd.
- Order Value: Rs 0.49 Crores
- Client: One of India’s largest retail pharmacy chains with over 5,000 outlets
- Location: Mumbai / Gujarat (Operations)
- Date: 5th August, 2025
Veerhealth Care Ltd. has secured a significant new order to manufacture and supply hair care products for one of the largest pharmacy chains in India, which operates more than 5,000 retail outlets nationwide. This opportunity is expected to contribute positively to the company’s business growth and turnover.
The order is to be completed within 45 days and has a contract value of Rs 0.49 Crores. The client details remain confidential, but it is a domestic entity from the pharmacy retail sector. Veerhealth Care’s production unit is located in Vapi, Gujarat, while its registered office is in Mumbai.
Also Read: Telecom Sector Stock Bags Rs 18.57 Crore MPLS Order from Airports Authority of India.
Key Fundamentals
- Market Cap: Rs 44.1 Crores
- Current Price: Rs 22.0
- 52 Week High/Low: Rs 25.8 / Rs 9.29
- Price to Earnings (P/E) Ratio: 113
- Book Value: Rs 11.1
- Dividend Yield: 0.00%
- Return on Capital Employed (ROCE): 3.14%
- Return on Equity (ROE): 1.77%
- Face Value: Rs 10
- Price to Book Value: 1.98
- Earnings Per Share (EPS): Rs 0.20
- Promoter Holding: 31.5%
- Industry P/E: 31.8
- EV/EBITDA: 28.5
- Market Cap to Sales: 2.64
- 3-Year Return: 53.3%
What This Means for Investors
This new contract with a top Indian pharmacy chain marks an important addition to Veerhealth Care’s order book, particularly in the hair care segment. The engagement with a nationwide retail network enhances the company’s visibility and opens avenues for further business in personal care products. With a clear timeline of 45 days for execution, the order reflects Veerhealth Care’s ability to secure and deliver on sizable projects domestically. These developments could positively influence future revenue streams and strengthen the company’s presence in the pharmaceuticals and personal care manufacturing sector.
Past Orders or Related News
Veerhealth Care announced on July 23, 2025, that it had secured approval from Gujarat’s Food and Drug Authority to produce personal care items. Following the approval, the company secured its first commercial order from one of India’s prominent marketplace companies for skin and face care products, valued at Rs 48,00,000, with a 30-day execution timeline.
Source: BSE (Click To Download PDF).
Disclaimer: The content on this page is for informational and educational purposes only and should not be construed as financial, investment, tax, or legal advice.
The author and publisher accept no liability for any losses or damages resulting from the use of this information.
